{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "regularMarketChangePercent": 4.705878, "regularMarketPrice": 2.225, "exchange": "LSE", "shortName": "HEMOGENYX PHARMACEUTICALS PLC O", "longName": "Hemogenyx Pharmaceuticals Plc", "messageBoardId": "finmb_534035013", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "marketState": "CLOSED", "esgPopulated": false, "sharesOutstanding": 1142000000, "bookValue": 0.003, "fiftyDayAverage": 2.0694, "fiftyDayAverageChange": 0.15559983, "fiftyDayAverageChangePercent": 0.07519079, "twoHundredDayAverage": 1.76899, "twoHundredDayAverageChange": 0.45600986, "twoHundredDayAverageChangePercent": 0.25777978, "marketCap": 25409500, "priceToBook": 741.6666, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1447056000000, "priceHint": 4, "regularMarketChange": 0.099999905, "regularMarketTime": 1683913263, "regularMarketDayHigh": 2.3, "regularMarketDayRange": "2.1 - 2.3", "regularMarketDayLow": 2.1, "regularMarketVolume": 7654358, "regularMarketPreviousClose": 2.125, "bid": 2.15, "ask": 2.3, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "GBP", "regularMarketOpen": 2.1924, "averageDailyVolume3Month": 5584811, "averageDailyVolume10Day": 6255140, "fiftyTwoWeekLowChange": 1.0749999, "fiftyTwoWeekLowChangePercent": 0.93478256, "fiftyTwoWeekRange": "1.15 - 4.3", "fiftyTwoWeekHighChange": -2.0750003, "fiftyTwoWeekHighChangePercent": -0.4825582, "fiftyTwoWeekLow": 1.15, "fiftyTwoWeekHigh": 4.3, "earningsTimestamp": 1682661606, "earningsTimestampStart": 1682661606, "earningsTimestampEnd": 1682661606, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "symbol": "HEMO.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "60 Gracechurch Street", "address2": "6th Floor", "city": "London", "zip": "EC3V 0HR", "country": "United Kingdom", "phone": "44 79 0917 7311", "website": "https://www.hemogenyx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vladislav  Sandler Ph.D.", "title": "Co-Founder, CEO & Director", "fiscalYear": 2021, "totalPay": {"raw": 213000, "fmt": "213k", "longFmt": "213,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Alexis M. Sandler J.D.", "title": "Independent Co-Founder & Non-Exec. Director", "fiscalYear": 2021, "totalPay": {"raw": 45000, "fmt": "45k", "longFmt": "45,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andrew  Wright", "title": "Financial Controller & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Koen  Van Besien M.D., Ph.D.", "title": "Clinical Advisor & Medical Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}